HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kaori Kashiwagi Selected Research

1-hexylindolactam-V10

1/2008Synthesis, conformational analysis, and biological evaluation of 1-hexylindolactam-V10 as a selective activator for novel protein kinase C isozymes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kaori Kashiwagi Research Topics

Disease

2Neoplasms (Cancer)
01/2008 - 02/2002
1Dysbiosis
01/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2009
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
02/2009
1Alzheimer Disease (Alzheimer's Disease)
01/2008
1Reperfusion Injury
01/2008
1Carcinogenesis
02/2002

Drug/Important Bio-Agent (IBA)

1Proton Pump InhibitorsIBA
01/2018
1Protein Kinases (Protein Kinase)IBA
02/2009
1IsoenzymesIBA
01/2008
11-hexylindolactam-V10IBA
01/2008
1Peptides (Polypeptides)IBA
02/2002
1bryostatin 1IBA
02/2002
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
02/2002
1CarcinogensIBA
02/2002
11-oleoyl-2-acetylglycerolIBA
02/2002